Indian Journal Watch: 27 October 2026

Indian Journal Watch, InfectionIndia.com

Indian Journal Watch

27 October 2026

Peer-reviewed microbiology, infectious disease, AMR and infection-control papers from India and South Asia, published or added to PubMed from 25 to 27 October 2026.

Lead articles

Vaccines · International Journal of Infectious Diseases

Effectiveness of an Inactivated Quadrivalent Influenza Vaccine in Children and Pregnant Women in Rural Bangladesh: A Phase IV Double-Blind, Cluster-Randomized Trial

International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.109209 · PubMed 42933529

What
A trial of the effectiveness of a quadrivalent inactivated influenza vaccine (QIV) among children under 5 and pregnant women in rural Bangladesh, led by icddr,b (Dhaka) with the Influenza Centre, University of Bergen, Norway.
Design
Phase IV, double-blind, cluster-randomised trial. Twenty villages in Matlab were randomised 1:1 to QIV or inactivated poliovirus vaccine (IPV) as control. Vaccination took place between April and June 2021, with follow-up surveillance through December 2022. Seventy-five pregnant women (28-34 weeks of gestation) received one dose and 2,736 children aged 6-59 months received two doses at a 4-week interval. Influenza-like illnesses were tested by real-time RT-PCR.
Key findings
During the influenza B/Victoria wave (April-August 2021), adjusted total vaccine effectiveness (VE) was 77.4% (95% CI: 47.4-90.3) in children and 77.9% (95% CI: 48.9-90.5) among all participants. Only two laboratory-confirmed influenza cases occurred among pregnant women, both in the control group. VE was low and non-significant during the influenza A/H1N1 wave and negative during the A/H3N2 wave. No indirect protection was observed among unvaccinated villagers.
Limitations
The small number of events among pregnant women precluded a reliable estimate of VE in this subgroup, and protection was not demonstrated against the influenza A waves. The trial was conducted in one rural area (Matlab).
Relevance to India
The authors conclude that the findings support including influenza vaccination for children in national programmes. Routine childhood influenza vaccination is not currently part of India’s Universal Immunisation Programme, and these are randomised effectiveness data from a neighbouring South Asian setting.

AMR · Indian Journal of Medical Microbiology

Comparison of Meropenem-based triple therapy vs Minocycline-based Triple therapy for Carbapenem Resistant Acinetobacter baumannii Ventilator Associated Pneumonia – A Prospective Observational Study

Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2026.101327 · PubMed 42933694

What
A comparison of two triple-antibiotic regimens for ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii (CRAB), from the Department of Anaesthesiology & Critical Care, AIIMS, Delhi, with co-authors including AIIMS, Nagpur.
Design
Prospective observational study in the critical care unit of an academic medical centre, January 2024 to March 2025. Two hundred adults with culture-proven CRAB-VAP were treated with either minocycline-polymyxin-sulbactam or meropenem-polymyxin-sulbactam. Outcomes were clinical recovery, 7- and 28-day mortality, microbiological eradication, and duration of ICU and hospital stay.
Key findings
Clinical recovery rates were comparable (54% minocycline vs 47% meropenem, p=0.322), and microbiological eradication was similar (39%) at day 28 in both groups. The minocycline group had significantly shorter ICU stay (16 vs 18 days, p=0.003) and hospital stay (24 vs 28 days, p<0.001). There was no significant difference in 7-day mortality (21% vs 32%, p=0.078) or 28-day mortality (46% vs 53%, p=0.322).
Limitations
Observational design without randomisation of the regimens, at a single critical care unit; the abstract does not describe how regimens were allocated or adjustment for baseline severity.
Relevance to India
The authors suggest minocycline may be a suitable alternative for CRAB-VAP in resource-limited settings. The study adds Indian ICU data on polymyxin-sulbactam-based combinations for CRAB.

More from the journals

Antimicrobial resistance & stewardship

IPC & healthcare-associated infection

Vaccines

Tuberculosis & leprosy

Vector-borne & parasitic disease

Virology & One Health

Mycology

Enteric fever

Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *